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Abstract
Objective: Cell structural changes are one of the main features observed during the 
development of amyotrophic lateral sclerosis (ALS). In this work, we propose the use 
of diffusion tensor imaging (DTI) metrics to assess specific ultrastructural changes in 
the central nervous system during the early neurodegenerative stages of ALS.
Methods: Ultra-high field MRI and DTI data at 17.6T were obtained from fixed, ex-
cised mouse brains, and spinal cords from ALS (G93A-SOD1) mice.
Results: Changes in fractional anisotropy (FA) and linear, planar, and spherical ani-
sotropy ratios (CL, CP, and CS, respectively) of the diffusion eigenvalues were meas-
ured in white matter (WM) and gray matter (GM) areas associated with early axonal 
degenerative processes (in both the brain and the spinal cord). Specifically, in WM 
structures (corpus callosum, corticospinal tract, and spinal cord funiculi) as the dis-
ease progressed, FA, CL, and CP values decreased, whereas CS values increased. 
In GM structures (prefrontal cortex, hippocampus, and central spinal cord) FA and 
CP decreased, whereas the CL and CS values were unchanged or slightly smaller. 
Histological studies of a fluorescent mice model (YFP, G93A-SOD1 mouse) corrobo-
rated the early alterations in neuronal morphology and axonal connectivity measured 
by DTI.
Conclusions: Changes in diffusion tensor shape were observed in this animal model 
at the early, nonsymptomatic stages of ALS. Further studies of CL, CP, and CS as im-
aging biomarkers should be undertaken to refine this neuroimaging tool for future 
clinical use in the detection of the early stages of ALS.
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1  | INTRODUC TION
The introduction of animal models has been one of the major steps 
forward towards a better understanding of the neuropathological pro-
cesses occurring in humans. Based on their similarity to the human ge-
nome and easy availability, mammalian murine models have been one 
of the most commonly used representations of neurodegenerative dis-
eases such as Amyotrophic Lateral Sclerosis (ALS).1 As such, the phe-
notypical expression and histological discoveries parallel many of the 
symptomatology and neuropathological findings observed in patients 
with ALS.2,3 During the last decades, the exponential growth of novel 
genetic tools has led to the detection of new mutations in the patient 
population, and thus to help in the development of new transgenic ani-
mal models for research and therapeutic discovery purposes.4
From the original ALS mouse model representing the familiar 
form of ALS with the mutation of the superoxide dismutase 1 (G93A-
SOD1) gene,5 a growing number of rodent models that express dif-
ferent mutations, such as the fused in sarcoma (FUS),6 the C9orf72 
hexanucleotide repeat expansion mice,7,8 and the transactive re-
sponse DNA binding protein 43 kDa TDP-439,10 (among others) have 
been increasingly developed to address the effects of molecular 
changes on neuronal degeneration and death. However, such mod-
els represent less than 10% of the sporadic cases of ALS. Other mod-
els of sporadic ALS mutations, like the wobbler and VPS54 mice,11,12 
have been used aiming to understand the basic cellular mechanisms 
of motoneuron diseases, but these abnormalities are likely different 
from those occurring in ALS.1  Despite the growing availability of 
murine animal models, the G93A-SOD1 mouse model is the original 
and longer tested mammalian model of ALS up to date.13
In the last decades, the increasing development of MRI systems 
has been able to allow neuroscientists to analyze in real-time the neu-
ropathological process occurring in physiological intact biological sys-
tems.14,15 Also, the advances in computational power, hardware, and 
gradient strengths has been paramount in high-field resolution MRI 
particularly in small animal research.16-18 Since its inception, diffusion 
tensor imaging (DTI) has been applied as an imaging technique to eval-
uate not only microstructure but also the integrity and connectivity of 
different CNS regions.19 Diffusion tensor imaging provides a mathe-
matical model of diffusion anisotropy and is widely used. Parameters, 
including fractional anisotropy (FA), mean diffusivity (MD), as well as 
parallel and perpendicular diffusivity, can be derived to provide sen-
sitive, but nonspecific, measures of the altered tissue structure.20 The 
popularity of DTI has been based on its relatively simple computational 
algorithms based on the directionality of the diffusion tensor's eigen-
values.21 Therefore, this diffusion technique is one of the most widely 
utilized in the scientific and medical field to evaluate axonal injuries 
across different axonal tracts.22,23
The diffusion tensor can be visualized using an ellipsoid where the 
principal axes correspond to the directions of the eigenvector sys-
tem.24,25 By applying the symmetric properties of this ellipsoid, the 
diffusion tensor can be decomposed into basic geometric measures to 
describe the shape of the diffusion tensor models.26 In that regard, DTI 
derived parameters such as linear (CL), planar (CP), and spherical (CS) 
anisotropy have been only applied to evaluate hippocampal structures 
on preclinical models of epilepsy.27 Here, we extend this approach to 
characterize such DTI derived morphological parameters in the con-
text of ALS. In previous work, we used ultra-high field diffusion MRI 
(UHFD-MRI) to asses microstructural changes in gray and white mat-
ter (GM & WM) applied to different murine models of neurodegen-
erative diseases.28,29 Our results have shown that structural changes 
can be detected during earlier stages of the disease.14,30,31 In line with 
such studies, we postulate that the intrinsic geometrical properties of 
monoexponential diffusion signals derived from DTI could add another 
level of specific information in relation to different neuraxial structures. 
Hence, in this work we extended our previous investigations on DTI to 
analyze if parameters representing the DTI tensor contain additional 
information that: a) determine the specific geometrical characteristics 
of diffusion tensors across different neuronal tissue interrogated and 
b) to assess their value as additional biomarkers of disease in the con-
text of neurodegenerative diseases (ALS mice). To test  these hypothe-
ses, we analyzed CNS tissues of an animal model of ALS (G93A-SOD1 
mice) with UHF-MRI to determine the potential role of derived DTI 
anisotropic parameters in ALS.
2  | METHODS
2.1 | Theory
The tensor field data were diagonalized using the standard analyti-
cal methods and eigenvalues were obtained (λ1, λ2, and λ3) to calcu-
late Fractional Anisotropy (FA) as described in Eq. 1. Additionally, 
the tensor field was used to compute the DTI metrics, such as linear 
anisotropy (CL), planar anisotropy (CP), and spherical anisotropy (CS) 
as described in Equation 2, 3, 4, respectively.32,33
where; trace = (λ2 + λ2 + λ3)
FA and DTI metric maps were calculated, and a mean value 
of each parameter was extracted and calculated from each ROI 
(Figure 1).
2.2 | Animals
All procedures used to obtain tissues followed an approved protocol 
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at Chicago (UIC). In any situation of animal distress or pain, animals 
were sacrificed in carbon dioxide using standard protocols For MRI 
and histology imaging methods, ALS mice were obtained from the 
Jackson Laboratory (JAX#004435) and bred on a C57BJ6 back-
ground, overexpressing the SOD1 transgene with the G93A muta-
tion. The G93A-SOD1 mice in this background have been previously 
characterized and they develop motor symptoms at approximately 
110 days of age and die around 160 days.34,35 We considered three 
groups of animals for this work: a wild-type control group (WT), a 
presymptomatic group at postnatal day 80 (P80) and a symptomatic 
group at postnatal day 120 (P120). For MRI studies, a total of 12 ani-
mals were used: wild-type (WT) control (n = 4) and ALS (G93A-SOD1) 
mice (n = 4 per group). Mice had easy access to food and water and 
were checked daily to assess their level of well-being and health. 
Additional animals WT, P80, and P120 were used for further his-
tological analysis, Specifically, we evaluated morphologic neuronal 
anomalies in the context of ALS, using additional mouse reporters 
expressing a yellow fluorescent protein (YFP) transgene specifically 
associated with a neuronal Thy1 promoter, were chosen. The first 
reporter group was chosen for the high YFP expression in axons lo-
cated in spinal cord areas, the so-called YFP-J16 mice (JAX#003709). 
The second group of YFP mice was chosen for its mild fluorescent 
Thy1 expression and higher background, making it ideal to study in-
dividual neuronal structural details in the cerebral cortex and hip-
pocampus, so-called YFP-H mice (JAX#003782). Detailed molecular 
and neuronal population differences between both YFP reporters 
have been extensively described in previous work.36,37
2.3 | MRI and DTI protocol
Animals were rendered unconscious with CO2 inhalation, then tran-
scardially perfused with a PBS and 4% paraformaldehyde (PFA) 
solution. After the skull was opened, mouse brains were extracted 
intact and immersed in PFA (>48 hours). Before scanning, brains 
were soaked overnight in phosphate-buffered saline (PBS) (Corning 
cellgro, catalog #21-040-CV, lot#12417001) to remove free fixa-
tive. Three brains were stacked in a 10 mm inner diameter glass tube 
(Fisher Scientific, cat#14-961-26) and surrounded with fluorocarbon 
oil (Fluorinert®, 3M, Maplewood, MN). Images from brains were ac-
quired with a 17.6T vertical-bore Avance II scanner using a 25 mm 
RF coil. Spinal cords (SC) were placed on a 5 mm NMR tubes (New 
Era #NE-MQ5-7, 300-400 MHz) and scanned in a 5 mm RF coils as 
described in previous studies.38
F I G U R E  1   Anatomical maps and areas 
of segmentation in the ALS mouse. A, T2 
map anatomical representation of a mouse 
brain showing different white (WM) and 
gray matter (GM) segmented regions used 
for diffusion tensor imaging (DTI) metrics 
analysis. B, MRI diffusion map at b0 from 
a mouse spinal cord (SC). SC segmentation 
was centered in the lumbar WM and GM 
regions
F I G U R E  2   MRI Diffusion tensor derivatives in different tissues 
of a wild-type mouse. A, Diagram representing the different 
parameters used to assess tensors geometry, such as linear, planar, 
and spherical anisotropy (CL, CP, and CS, respectively) and its 
spatial relationship with eigenvalues (e). B, Representation of CL, 
CP, and CS in Bayesian coordinate plots across different central 
nervous system (CNS) region in a wild-type rodent (WT). Note 
that different gray and white matter structures yield tensors with 
a unique & different geometry. Animals (n = 4), *P < .05, **P < .01. 
Abbreviations: WM, white matter; GM, gray matter; CC, corpus 
callosum; CST, corticospinal tract; CCX, cortex; Hipp, hippocampus; 
SCwm, spinal cord white matter; SCgm, spinal cord gray matter
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Two imaging sessions of six mouse brains (N = 12), with a total 
of 170 MRI slices were acquired, coronally centered and oriented 
along the rostral-caudal axis of each brain. Additionally, a group 
of six spinal cords was imaged (16 axial slices per SC) using an ac-
quisition centered in the lumbar region. For all the scans, diffu-
sion-weighted images were acquired using a spin-echo sequence 
with TR = 10 000 ms and TE = 20 ms, interleaved 0.2-mm-thick 
slices, field of view = 25 × 25 × 34 mm3 in each block of slices, in-
plane acquisition matrix = 125 × 125 × 170, for an isotropic image 
resolution of 200 μm. A multi-slice 2D acquisition was used for all 
the samples. Diffusion-weighted images were acquired in the cool 
bore (20°C) of the magnet with b = 0 s/mm2 with b = 1000 s/mm2 in 
20 directions. The acquisition time was approximately 19 hours per 
session. FSL software was used to calculate each eigenvalue and 
the anisotropy parameters.39 ROIs from each central nervous sys-
tem structure  were manually segmented following anatomical land-
marks described in the standard stereotaxic coordinate mouse brain 
and spinal cord atlases and data extracted using ITK-SNAP.40
2.4 | Histology
After MRI scanning, oil media was removed, and brains were placed 
in increasing concentration of sucrose solutions [5%-30%] for an ad-
ditional 24 hours for cryo-protection. After embedding in optimal 
cutting temperature (OCT) polymer compound (Tissue Tek, Sakura, 
Finetek, cat #4583), 50-µm-thick brain sections were obtained using 
a microtome (Leica cryostat CM 1850 Cryostat, Buffalo Grove, IL). 
Brain sections were mounted on slides (Fisher-brand Superfrost cat# 
12-550-15) and dried for 15 minutes. Then, the OCT was removed 
by washing three times with Tris base buffer (TBS). Slides were dried 
and mounted in Vecta-Shield mounting media (Vector Laboratories, 
Burlingame, CA). Cortical and hippocampal images of the YFP(H) 
mice reporter group were acquired with a Carl Zeiss structural 
confocal microscope (ApoTome.2, Oberkochen, Germany). Imaging 
of the spinal cord was performed on a subset of YFP(J16) mouse 
brain slices on a confocal Olympus microscope (FluoView FV1000, 
Shinjuku, Tokyo, Japan). Representative histological sections were 
TA B L E  1   Summary of DTI Derivative Results in CNS structures of Preclinical Animal Models of Neurodegenerative Diseases
 Control (WT) Presymptomatic (P80) Symptomatic (P120)
Cortex (Prefrontal) FA 0.160 ± 0.004 0.140 ± 0.002 (↓13%)* 0.120 ± 0.006 (↓25%)**
CL 0.050 ± 0.003 0.050 ± 0.001 0.050 ± 0.002
CP 0.090 ± 0.004 0.070 ± 0.002 (↓22%)* 0.070 ± 0.001 (↓22%)**
CS 0.860 ± 0.001 0.870 ± 0.003 0.880 ± 0.003
Hippocampus FA 0.180 ± 0.009 0.150 ± 0.010 (↓16%)* 0.130 ± 0.007 (↓27%)**
CL 0.060 ± 0.003 0.060 ± 0.005 0.050 ± 0.006 (↓16%)*
CP 0.100 ± 0.005 0.080 ± 0.002 (↓20%)* 0.070 ± 0.005 (↓30%)**
CS 0.830 ± 0.008 0.860 ± 0.011 0.880 ± 0.002
Spinal Cord (GM) FA 0.220 ± 0.009 0.200 ± 0.004 0.180 ± 0.007 (↓21%)**
CL 0.080 ± 0.002 0.070 ± 0.003 (↓13%)* 0.060 ± 0.005 (↓25%)**
CP 0.140 ± 0.007 0.120 ± 0.002 (↓14%)* 0.110 ± 0.006 (↓ 21%)**
CS 0.790 ± 0.008 0.810 ±0.004 0.830 ± 0.008
Corpus Callosum 
(Genu & Body)
FA 0.420 ± 0.013 0.330 ± 0.017 (↓21%)** 0.300 ± 0.017 (↓29%)**
CL 0.200 ± 0.004 0.140 ± 0.009 (↓30%)** 0.120 ± 0.006 (↓40%)**
CP 0.160 ± 0.003 0.140 ± 0.006 (↓13%)* 0.130 ± 0.005 (↓18%)*
CS 0.650 ± 0.004 0.720 ± 0.014 (↑11%)* 0.740 ± 0.010 (↑14%)*
Cortico-Spinal Tract 
(CST)
FA 0.460 ± 0.006 0.410 ± 0.010 (↓11%)* 0.370 ± 0.012 (↓20%)**
CL 0.230 ± 0.011 0.200 ± 0.008 (↓13%)* 0.180 ± 0.013 (↓22%)**
CP 0.150 ± 0.007 0.130 ± 0.004 (↓13%)* 0.110 ± 0.007 (↓27%)**
CS 0.620 ± 0.018 0.680 ±0.005 (↑10%)* 0.710 ± 0.015 (↑15%)*
Spinal Cord (WM) FA 0.640 ± 0.011 0.560 ± 0.06 (↓13%)* 0.510 ± 0.025 (↓20%)**
CL 0.410 ± 0.006 0.350 ± 0.010 (↓15%)* 0.290 ± 0.019 (↓29%)**
CP 0.150 ± 0.003 0.150 ± 0.008 0.140 ± 0.006
CS 0.440 ± 0.004 0.490 ± 0.004 (↑ 11%)* 0.560 ± 0.024 (↑ 27%)**
Note: Values as mean ± SEM.
Abbreviations: ↑%, percentage increase from wild-type; ↓%, percentage decrease from WT; ALS, amyotrophic lateral sclerosis; CL, linear anisotropy; 
CNS, central nervous system; CP, planar anisotropy; CS, spherical anisotropy; FA, fractional anisotropy; WT, wild-type.
*P < .05 from control; 
**P < .01 from control. 
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selected matching stereotaxic coordinates.41,42 Fluorescent confocal 
microscopy images were obtained with a 534 nm laser channel using 
standard techniques previously described29,37 and images processed 
using ImageJ software.43,44
2.5 | Statistical analysis
Quantitative data were tabulated and analyzed using statistical 
GraphPad Prism 6 software (La Jolla, CA). Minimum group size of 
animals per experimental group was established using power analy-
sis and sample size calculations based on the results from prelimi-
nary experiments. For quantitative analysis, one-way ANOVA and 
Tukey's post hoc tests were used to determine statistical differences 
among experimental animal groups. A value of P < .05 was used to 
demonstrate statistical significance. Results were replicated by the 
application of nonparametric statistical tools (Mann-Whitney test). 
Error bars in all the figures represent standard error of the mean 
(SEM).
3  | RESULTS
3.1 | Each neuronal tissue structure in the mice 
corresponded to a specific DTI metric
Initial analyses were centered on three different WM and three GM 
structures (Figure 1). Following the literature, FA values in GM were 
significantly lower than in WM, demonstrating a higher degree of 
complexity and anisotropy in such structures. For example, for GM 
structures such as the prefrontal cortex (CCX), and the hippocam-
pus (hipp), the values of FA were 0.16 ± 0.004 and 0.18 ± 0.009, 
respectively, whereas for the spinal cord GM (SCgm) the FA was 
0.22 ± 0.009. Conversely, for WM structures such as the anterior 
segment of the corpus callosum (CC), the cortico-spinal tract (CST), 
and the WM of the spinal cord (SCwm) the FA values were as fol-
lows: 0.42 ± 0.013, 0.46 ± 0.006, and 0.63 ± 0.01, respectively 
(Figure 2). Overall, the CL was greater in WM than GM regions, the 
CP was slightly greater in WM structures, and the CS was substan-
tially greater in the GM. Interestingly, SCwm had a larger CL and CS 
values when compared to other WM regions (Table 1). As such, ten-
sor metric differences across each WM tracts can be accounted for 
their specific eigenvalues, marking the proportion of crossing fibers 
on each WM structure (Figure 3).
3.2 | Progressive and distinct changes in DTI 
metrics can be observed across different neuraxial 
regions of the ALS mice
As the disease progressed, DTI derived parameters changed ac-
cordingly. Overall, greater decreases in CL was observed in WM 
structures at presymptomatic (P80) and symptomatic stages (P120) 
in the anterior segment of the CC: (WT CL = 0.200 ± 0.004) vs (P80 
CL = 0.140 ± 0.009, P < .01) vs (P120 CL = 0.120 ± 0.006, P < .01), 
in the CST: (WT CL = 0.230 ± 0.011) vs (P80 CL = 0.200 ± 0.008, 
P < .05) vs (P120 CL = 0.180 ± 0.010, P < .01), as well as in the 
SCwm: (WT CL = 0.410 ± 0.006) vs (P80 CL = 0.350 ± 0.010, 
P < .05) vs (P120 CL = 0.290 ± 0.019, P < .01). Although relatively 
larger CP changes were seen in GM structures such as the CCX 
and Hipp, greater changes in CS were seen in all the WM struc-
tures studied, such as the CC: (WT Cs = 0.650 ± 0.004) vs (P80 
Cs = 0.720 ± 0.014, P < .05) vs (P120 Cs = 0.740 ± 0.010, P < .05), 
and the CST: (WT Cs = 0.620 ± 0.018) vs (P80 Cs = 0.680 ± 0.005, 
P < .05) vs (P120 Cs = 0.710 ± 0.015, P < .05); with broader 
changes found in the SCwm regions (WT Cs = 0.440 ± 0.004) vs 
(P80 0.490 ± 0.004, P < .05) vs (P120 Cs = 0.560 ± 0.024, P < .001) 
(Table 1). Overall, the changes detected for DTI-derived param-
eters were more prominent in WM compared with GM structures 
(Figure 4). Ground truth underlying these MRI results can be seen 
in the microstructural changes observed in histological prepara-
tions of GM (Figure 5).
F I G U R E  3   Asymmetry across geometric planes of diffusion 
tensors are associated to tissue complexity in the spinal cord of 
the ALS mouse. A, Diffusion tensor diagram showing relative 
differences in white matter spinal cord (SC) eigenvalues (e) in a 
naïve mouse. In the perpendicular view of the tensor, note the 
asymmetry between e2 and e3 (above). Tridimensional complexity 
and tissue inhomogeneities could be associated to the relative 
proportion of axonal fibers crossing from the gray matter region 
exiting on each spinal cord root (diagram below). B, Perpendicular 
histological section from a lumbar spinal cord region in a YFP 
axon labeled mouse showing a representative region of crossing 
fibers. C, Higher magnification of the square area revealed a highly 
prevalent population of crossing axons (arrows). Abbreviations: YFP, 
yellow fluorescent protein; WM, white matter; GM, gray matter. 
Scale bar in Figure 3B = 1 mm. Scale bar in Figure 3C = 10 microns
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F I G U R E  4   Longitudinal changes in tensor derived geometry across different white and gray matter neuraxial tissues (wild-type vs 
presymptomatic and symptomatic G93A-SOD1 mouse). A,C,E, Representation of fractional anisotropy (FA) and tensor geometries measured 
in cerebral superficial gray matter (GM) regions in the prefrontal cortex (CCX) (A), deep GM regions, such as the hippocampus (C) as well as 
the GM portion of the spinal cord (SCgm) (E) captured by linear, planar, and circular anisotropy (CL, CP, and CS, respectively). B, D, F, Analysis 
of tensor metrics changes in cerebral white matter (WM) regions, such as the corpus callosum (CC) (B) and the corticospinal tract (CST) (D) 
as well as in the WM region of the lumbar spinal cords (SCwm) (F). Note the relatively small change in tensor shape between the control (WT) 
group and the presymptomatic (P80) and symptomatic (P120) animal groups in GM, vs the wider changes in WM structures. Animals (n = 4), 
*P < .05, **P < .01. Abbreviations: WM, white matter; GM, gray matter; CC, corpus callosum; CST, corticospinal tract; CCX, cortex; Hipp, 
hippocampus; SCwm, spinal cord white matter; SCgm, spinal cord gray matter
F I G U R E  5   Early structural anomalies in neuronal connectivity can be detected in the cortical gray matter of the YFP-G93A-SOD1 
mouse. A, Yellow Fluorescent Protein (YFP) expression in neurons of the prefrontal cortex showed a significant impairment in neuronal 
architecture in the ALS mice (arrow). B, YFP expression in different segments of the hippocampus, such as the dental gyrus (DG), cornus 
Ammonis 1 (CA1), and cornus Ammonis 3 (CA3) showed early structural anomalies in dendritic and axonal structures (arrows) in the ALS 
mouse. Abbreviations: ALS, Amyotrophic Lateral Sclerosis; Hipp, Hippocampus; DG, dental Gyrus; CA1, Cornus Amonus segment 1; CA3, 
Cornus Amonus segment 3; CCX, cortical region; Hipp, hippocampus. Scale bar in Figure 5A, B = 10 microns
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3.3 | Assessing differential structural diffusion 
tensor changes in specific spinal cord regions of the 
ALS mice
Expanding previous animal ALS studies,29 we used UHF-MRI to de-
scribe the histological structural changes occurring in the spinal cord 
of the ALS mouse (Figure 6). We analyzed specific WM ROIs of the 
lumbar spinal cord, such as the anterior funiculi (Af), lateral fasciculi 
(Lf), and posterior fasciculi (PF) as well as the gray matter anterior 
horn (GMah). Changes in DTI derivatives across different funiculi 
(WT vs P120 ALS mice) demonstrated higher variations compared 
to SC GM. As an example, in the Af region variables were as fol-
lows: (WT CL = 0.390 ± 0.009) vs (P120 CL = 0.296 ± 0.020, 16% 
decrease), (WT Cp = 0.152 ± 0.009) vs (P120 Cp = 0.135 ± 0.005, 11% 
decrease), and (WT Cs = 0.477 ± 0.013) vs (P120 Cs = 0.567 ± 0.023, 
13% increase). As such, lower variation was seen in GMah; (WT 
CL = 0.075 ± 0.002) vs (P120 CL = 0.067 ± 0.004, 6% decrease), (WT 
Cp = 0.132 ± 0.006) vs (P120 Cp = 0.115 ± 0.002, 9% decrease), and 
(WT Cs = 0.792 ± 0.008) vs (P120 Cs = 0.822 ± 0.007, 6% increase) 
(Figure 7).
4  | DISCUSSION
The use of transgenic animal models imposes a significant advantage 
in neurobiology in the detailed analysis of biomarkers.45 Despite the 
recent introduction of additional animal models of ALS,46,47 the vast 
majority of preclinical mammalian studies are based on rodents.48 
The possibility of neuronal labeling fusing specific fluorescent tags 
has allowed neuroscientists to use the tagged fusion expressed 
in the animals not only to improve the visualization of axonal de-
generation in diverse experimental conditions but also as a ground 
F I G U R E  6   Structural fluorescent changes in different gray and white matter regions of the ALS mouse spinal cord. A, Lumbar spinal 
cord (SC) cross section of an ALS transgenic mouse labeled with yellow fluorescent protein (upper figure). Anterior area of the SC area at 
higher magnification in the anterior region (lower figure). Higher magnification of white matter and gray matter regions of interest (ROIs) 
are marked (squared dots). B, Fluorescent microscopic imaging of different WM ROIs, such as the anterior funiculi (Af), lateral funiculi (LF), 
and posterior funiculi (Pf) and additional optical imaging of the gray matter anterior horn (GMah). C, Fluorescent comparative images from 
ALS mouse at presymptomatic (P80) (right side) and symptomatic (P120) stages (left side). Note the axonal degeneration pattern in different 
WM ROIs and the increase in neuropil entanglement and tissue complexity in the GMah region as disease progresses (arrows). Nuclear 
counterstaining with propidium iodine (red). Scale bar in Figure 6A = 1 mm. Scale bar in Figure 6B, C = 10 microns. Abbreviations: WM, white 
matter; GM, gray matter. Af, anterior funiculi; Lf, lateral funiculi, Pf, posterior funiculi
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truth to enhance our understanding and characterization of MRI 
diffusion signals.49-51 In recent years, DTI metrics have been used 
in several  neuro-oncological,52-55 as well as neuroinfectious56-59 
clinical scenarios (Table 2). In oncological conditions, a decrease in 
CP and CL was associated with an increase in CS, probably due to 
a significant increase in tissue cellularity. In neurological and extra 
neurological60 inflammatory pathologies, the CP and CL component 
increased with a correlative drop in the CS component, possibly re-
lated to the increase in edema and the redistribution of the intra and 
extracellular components, similar to tensor metric measurements in 
chronic brain edema scenarios due to metabolic pathologies (liver 
failure).61,62 Although DTI metrics have been a useful imaging marker 
to neuromonitoring various clinical neuropathological processes, the 
underlying microstructural changes have not been fully explored, 
particularly in the context of basic neurodegenerative diseases re-
search. During its progression, neurodegenerative diseases combine 
several complex elements of neuroinflammation and microstructural 
remodeling across different cellular compartments that are fairly 
documented in vitro,63-68 as well as in vivo14,30,69,70 experimental 
models, but still require further characterization. Thus, this is the 
first study to apply DTI metrics to investigate the effects of neuro-
degenerative disease in an ALS transgenic murine model.
In this study, we analyzed the structural anomalies from the im-
aging & tensor shape perspective. The findings presented here aim 
to advance our current understanding of neurodegenerative disease 
in experimental models by providing additional information about 
the early pathological and microstructural changes in an ALS mouse 
model. Our results from our preclinical model indicated an overall lon-
gitudinal reduction in CP and CL as well as an increase CS (contrary to 
what would be expected) due to a decrease in cellular elements during 
the neurodegenerative process and resembling the neurooncological 
hyperproliferative clinical scenarios described before. Nevertheless, 
even though an initial increase in cellular elements could occur as a 
consequence of the neuroinflammatory and infiltrative processes well 
documented in the literature71-75; it is also possible that a relative re-
duction of the neuraxial volume could determine a relative increase in 
cellular density as described in our previous histological finding.29,38
Previous DTI work in canine animal models determined that the 
distribution of data for the WM internal capsule differed markedly 
from the WM centrum semiovale region.33 Furthermore, data for the 
internal capsule were distributed in a relatively tight cluster, possi-
bly reflecting the compact and parallel nature of its fibers, whereas 
data for the centrum semiovale were more widely distributed, con-
sistent with the less compact and often crossing pattern of its fi-
bers. This indicates that the tensor shape plot technique can depict 
data in similar WM regions as being alike, adding more specificity to 
these parameters. Results presented in our studies (Table 2) have 
shown a clear difference in tensor geometry between WM (CC, CST, 
and SCwm) and GM (CCX, Hipp, and SCgm) neuraxial structures. A 
careful look at each tensor shape has shown significant differences 
within cranial (CC and CST) and extracranial (SCwm) fiber structures 
(Figure 2). Thus, it is possible that such differences can be biologi-
cally explained by the fiber's content and the proportion of different 
fiber orientations, imprinting an asymmetry in the eigenvalues and 
further relation with the tensor shape, as corroborated by fluores-
cent microscopy evaluations (Figure 3) and previous studies.76 For 
instance, The Cs values across different WM tracts in WT animals 
indeed show differences that could reaffirm our idea of diffusion 
tensor asymmetries based on the number of crossing fiber popula-
tions (Figure 3A). As the populations of fibers in SCwm as well in CST 
are mostly formed by fibers leaning in one axis with limited contri-
bution from additional cortical fibers (CST)77 or root fibers (SCwm)76 
(Figure 3B,C). Alternatively, higher CS values from CC regions could 
be explained due to a significant amount of diverse axonal layers 
from fibers oriented orthogonal or in oblique directions as observed 
in other neurodegenerative fluorescent studies.36
During the disease progression, we observed a significant vari-
ation in diffusion tensor shapes across different structural regions 
primarily affected in ALS (Figure 4). Particularly, our studies on the 
relative changes in tensor metrics detected broader geometrical dif-
ferences in WM than in GM structures. These findings contradict 
a growing number of reports focused on alterations due to cortical 
F I G U R E  7   Changes in DTI metrics across different regions of 
spinal cord in the ALS mice. A, Lumbar FA map of the ALS mice 
showing the segmentations from different WM ROIs, such as the 
anterior funiculi (Af), lateral funiculi (Lf), and posterior funiculi (Pf) 
and gray matter (GM) anterior horn (GMah) areas matching previous 
histological regions in Figure 6. Scale bar = 1 cm. B, Analysis of 
DTI derivatives from WM and GM showed increased differences 
between WT and ALS mice compared in GM region indicating 
that  Gaussian DTI metrics can better capture differences in 
WM between control and ALS mice than changes in GM. Scale 
bar = 10 microns. Animals (n = 4), *P < .05, **P < .01. Abbreviations: 
WM, white matter; GM, gray matter. Af, anterior funiculi; Lf, lateral 
funiculi, Pf, posterior funiculi
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and subcortical remodeling as part of complex ultrastructural den-
dritic changes occurring in the earlier stages of ALS78-81 linked to 
behavioral alterations and frontotemporal dementia.37,82 These find-
ings were corroborated by microstructural changes in cortical and 
hippocampal subregions by our YFP-G93A-SOD1 histological prepa-
rations (Figure 5).
Further fluorescent microscopy analysis targeting SC sub-
regions showed that the degeneration process across WM sub-
regions was not equally distributed, demonstrating an early 
and selective axonal pathology and subsequent disconnection 
(Figure 6). Such disparity can also be appreciated in the anterior 
region of the ALS mouse brains, as shown in our original studies. 
As such, (particularly at the lumbar SC regions) specific changes 
across different fasciculi have shown earlier and broader DTI ge-
ometry changes, compared to SCgm as the disease progresses 
(Figure 7). In a practical approach, this finding could lead to the 
documentation of unique brain tissue identifiers leading to an 
increased optimization of bioimaging markers susceptible to the 
disease (Figure 8).  Despite we detected a high proportion of neu-
ro-axonal content  in the areas interrogated, additional neuroin-
flammatory process should be considered as a factor for tissue 
alterations.63,71 In consequence, the combination of diverse neu-
rodegenerative mechanisms in susceptible neuronal populations 
could determine the microstructural remodeling process occurring 
during the development of the disease, and influence the specific 
tensor geometries observed in the ALS mouse.
The validity of animal models for the study of human diseases 
such as ALS has been often criticized particularly due to their high 
phenotypical dependence on their genetic background.83,84 From 
the technical standpoint of MRI diffusion techniques, the biological 
validity of the results have been often undermined due to the signif-
icant resolution mismatch (voxel vs cell sizes), leading to a structural 
TA B L E  2   Previous applications of diffusion tensor imaging derivatives across different pathological conditions
Study design Pathology & tissue structure FA CL CP CS Citation
Rodent model 
(Pilocarpine 
& Kainic acid 
induced)
Epilepsy [Hippocampus DG] Increased Increased Increased Decreased Salo et al27
Clinical Brain tumor [Low vs High grade 
Glioma]
Decreased Decreased Decreased Increased El-Serougy et al52
Clinical Brain tumor [Glioblastoma] Decreased Decreased Decreased Increased Cortez-Conradis 
et al53
Clinical Brain tumor [WM tracts around 
Glioblastoma]
Decreased Decreased Decreased & 
NS changes
Increased Mormina et al55
Clinical Brain tumor [Glioblastoma] Decrease Decreased NS changes Increase Roldan-Valadez 
et al54
Clinical Neurocysticercosis [Vesicular to 
Calcified stage]
Increased Increased Increased Decreased Gupta et al58
Clinical Brain abscess [Hemorrhagic vs 
Nonhemorrhagic wall]
Increased Increased — Decreased Gupta et al89
Clinical Brain tumor [High vs Low grade 
Infiltrating Astrocytoma]
Increased — — Decreased Jolapara et al90
Clinical Brain tumor [Glioblastoma] Decreased Decreased Decreased Increased Saksena S et al91
Clinical Brain tumor [Atypical vs Benign 
Meningiomas]
Increased Increased Increased Decreased Jolapara et al92
Clinical Brain abscess [Wall vs Cavity] Increased Increased Increased Decreased Gupta et al56
Clinical Epidermoid Cyst Decreased Decreased Decreased — Santosh et al93
Clinical Epidermoid cyst [Lesion vs WM] Decreased Decreased Increased Increased Jolapara et al94
Clinical Synovial inflammation [Synovial 
tissue]
Increased Increased Increased Decreased Agarwal et al60
Clinical Brain tuberculoma Increased Increased Increased Decreased Gupta et al59
Clinical Brain tumor [Low-grade Gliomas 
after Radiotherapy] (WM)
Decreased Decreased Decrease Increased Haris et al95
Clinical Acute on chronic LF [Cerebral Brain 












Clinical Acute LF [Brain Edema] Decreased Decreased Decrease Increased Rai et al62
Note: Abbreviations: (—) no data; CL, linear anisotropy; CP, Caudate putamen; CP, planar anisotropy; CS, spherical anisotropy; WM, White matter; DG, 
Dental Gyrus; FA, fractional anisotropy; FWM, frontal White matter; GM, Gray matter; IC, internal capsule; LF, liver failure; NS, nonsignificant.
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oversimplification of the neurobiological structures representations. 
Despite the exceptional quality of the UHD-MRI data, none of the 
methods demonstrated high anatomical accuracy, which is highly de-
pendent upon parameters of the tractography algorithm. These inac-
curacies (highly dependent on acquisition protocol differences) are 
particularly predominant in scenarios such as long-range anatomical 
projections (based on voxel averaged estimates of local fiber orien-
tation) as well as in WM regions of multiple crossing fibers.85,86 From 
our dataset, significant changes in FA (parameter related to tissue 
organization) were not necessarily followed by changes in DTI met-
rics, indicating the limitations of these biomarker to describe com-
plex changes in highly heterogenous media. Also, SOD pathology 
includes not only axonal degeneration, but there can also be other 
changes such as structural and cellular changes including demyelin-
ation, microglial activation among others, which would be more pro-
nounced at the later stage.38,87 As such, different neuropathological 
changes can contribute to diffusion anisotropy changes in other 
neurodegenerative diseases. In that regard, our future studies will 
focus on these diffusion derivative parameters in the context of 
other experimental animal models of neurodegenerative diseases. 
Lastly, the interrogation of alterations observed in complex brain mi-
crostructures (superficial and deep GM regions) could also be limited 
by the exclusive use of Gaussian diffusion models. Thus, additional 
implementation of multi-exponential diffusion models28,88 will be re-
quired for more accurate representation to improve monitoring, as 
well as testing new therapeutic strategies in ALS.
5  | CONCLUSIONS
Anisotropic components of DTI can be used to extract specific mi-
crostructural information in a murine model of ALS. Clear differences 
F I G U R E  8   Diagram showing specific 
geometric changes of diffusion tensors 
among different neuraxial structures 
in the ALS mice. A, Changes in gray 
matter (GM) regions: prefrontal cortex, 
hippocampus and spinal cord GM. 
B, Changes in CL, CP, and CS metrics 
across different white matter (WM); 
corpus callosum, cortico-striatal tract, 
and spinal cord. Changes in WM 
and GM are probably associated to 
specific neuropathological alterations 
in cellular shape, probably due to 
neuroinflamatory processes as well 
as remodeling of intracellular and 
extracellular compartments. C, Diagram 
showing progressive changes in tissue 
organization due to ALS measured by 
fractional anisotropy (FA) in different 
WM and GM structures. Abbreviations: 
IC, intracellular compartment; EC, 
extracellular compartment; CC, corpus 
callosum; CST, corticospinal tract; CCX, 
cortex; Hipp, hippocampus; STR, striatum; 
SCwm spinal cord white matter. SCgm spinal 
cord gray matter; WM, white matter; GM, 
gray matter
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were observed across different WM neuraxial structures. However, 
the information obtained on the progression of the disease in this 
ALS model was limited in the case of GM. Exploring these biomark-
ers further using anomalous diffusion techniques could represent 
a step forward to understanding the neuropathological processes 
linked to ALS and provide a new tool to detect early markers and 
monitor potential treatments.
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